VEGFA and amyotrophic lateral sclerosis: VEGF delivery to SODG93A transgenic mice (a classical model of ALS) by different gene therapies yields to a significant delay in the onset of motor deficits, slows motoneuron degeneration and prolongs survival (Azzouz et al., 2004; Wang et al., 2007, 2016).